Serum paraoxonase activity and oxidative stress and their relationship with obesity-related metabolic syndrome and non-alcoholic fatty liver disease in obese children and adolescents

Journal of Pediatric Endocrinology and Metabolism

Volumn 27, Issue 7-8, 2014, Pages 667-675

  Torun, Emel ^a   Gökçe, Selim ^a   Ozgen, Ilker Tolga ^a   Aydin, Sinem ^a   Cesur, Yasar ^a  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

Author keywords

Hepatosteatosis; Paraoxonase; Total antioxidant stress; Total oxidant stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ARYLDIALKYLPHOSPHATASE; C REACTIVE PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTIOXIDANT;

ADOLESCENT; ADOLESCENT DISEASE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CHILD; CHILDHOOD DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE CLASSIFICATION; ECHOGRAPHY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; BLOOD; CHILDHOOD OBESITY; COMPLICATION; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PHYSIOLOGY;

ADOLESCENT; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; CHILD; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; NON-ALCOHOLIC FATTY LIVER DISEASE; OXIDATIVE STRESS; PEDIATRIC OBESITY;

EID: 84907169811     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/jpem-2013-0337     Document Type: Article

References (36)

1. Kim CH, Younossi ZM. Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome. Cleve Clin J Med 2008;75:721-8
2. Pagano G, Pacini G, Musso G, Gambino R, Mecca F, et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiological ass ociation. Hepatology 2002;35:367-72
3. Baskol G, Baskol M, Kocer D. Oxidative stress and and antioxidant defences in serum of patients with non-alcoholic steatohepatitis. Clin Biochem 2007;40:776-80
4. Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endoc Metab 2008;93:9-30
5. Mackness MI, Mackness B, Durri gton PN. Paraoxonase and coronary heart disease. Atherosclerosis 2002;3:49-55
6. Camps J, Marsillach J, Joven J. The paraoxonases: role in human diseases and methodological difficulties in measurement. Crit Rev Clin Lab Sci 2009;46:83-106
7. Bhattacharyya T, Nicholls SJ, Topol EJ, Zhang R, Yang X, et al. Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional ac tivity with systemic oxidative sterss and cardiovascular risk. J Am Med Assoc 2008;299:1265-76
8. Koncsos P, Seres I, Harangi M, Illyes I, Jozsa L, et al. Human paraoxonase-1 activity in childhood obesity and its relation to leptin and adiponectin levels. Pediatr Res 2010;67:309-13
9. Li HL, Liu DP, Liang CC. Paraoxonase gene polymorphisms, oxidative stress and diseases. J Mol Med 2003;81:766-79
10. Barlow SE, and the Expert Committee. Expert commit tee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Paediatrics 2007;120:164-92
11. National High Blood Pressure Education Programm e Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Paediatrics 2004;114:555-76
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9
13. Valerio G, Licenziati MR, Iannuzzi A, Franzese A, Siani P, et al. Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy. Nu tr Metab Cardiovasc Dis 2006;16:279-84
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Programme ( NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation 2002;106:3143-421
15. Kim SH, Lee JM, Kim JH, Kim KG, Han J K, et al. Appropriateness of a donor liver with respect to macrosteatosis: application of artificial neural networks to US images-initial experience. Radiology 2005;234:793-803
16. Erel O. A novel automated direct measurement method for total antioxidant capacity using a new generation more stable ABTS radical cation. Clin Biochem 2004;37:277-85
17. Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem 2005;38:1103-11
18. Kosecik M, Erel O, Sevinc E, Selek S. Increased oxidative stress in children exposed to passive smoking. Int J Cardiol 2005;100:61-4
19. Eckerson HW, Wyte MC, La Du BN.The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet 1083;35:1126-38
20. Yang S, Zhu H, Li Y, Lin H, Gabrielson K, et al. Mitochondrial adaptations to obesity-related oxidant stress. Arch Biochem Biophys 2000;378:259-68
21. Videla LA, Rodrigo R, Orenella M, Fernandez V, Tapia G, et al. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin Sci (Lond) 2004;106:261-68
22. Koruk M, Taysi S, Savas MC, Yʇlmaz O, Akçay F, et al. Oxidative stress and enzymatic status in patients with nonalcoholic steatohepatitis. Ann Clin Lab Sci 2004;34:57-62
23. Nobili V, Manco M, Devito R, Di Ciommo V, Comparcola D, et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 200 8:48:119-28
24. Pirgon O, Bilgin H, Cekmez F, Kurku H, Dundar BN. Association between insulin resistance and oxidative stress parameters in obese adolescents with non-alcoholic fatty liver disease. J Clin Res Pediatr Endocrinol 2013;5:33-9
25. Krystek-Korpacka M, Patryn E, Hotowy K, Czapinska E, Majda J, et al. Paraoxonase (PON)-1 activity in overweight and obese children and adole scents: association with obesityrelated inflammation and oxidative stress. Adv Clin Exp Med 2013;22:229-36
26. Sumegova K, Nagyova Z, Waczulikova I, Zitnanova I, Durackova Z. Activity of paraoxonase 1 and lipid profile in healthy children. Physiol Res 2007;56:351-7
27. Tomas M, Senti M, Garcia-Faria F, Vila J, Torrents A, et al. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients. Arteroscler Thromb Vasc Biol 2000;20:2113-9
28. Whaley-Connell A, Mc Cullough PA, Sowers JR. The role of oxidative stress in metabolic syndrome. Rev Cardiovasc Med 2011;12:21-9
29. Tabur S, Torun AN, Sabuncu T, Turan MN, Celik H, et al. Non-diabetic metabolic syndrome and obesity do not affect serum para oxonase and arylesterase activities but do affect oxidative stress and inflammation. Eur J Endocrinol 2010;162:535-41
30. Hansel B, Giral P, Nobecourt E, Chantepie S, Bruckert E, et al. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high density lipoprotein particles displaying impaired antioxidative activity. J Clin Endocrinol Metab 2004;89:4963-71
31. Senti M, Tomas M, Fito M, Weinbrenner T, Covas MI, et al. Antioxidant paraoxonase 1 activity in metabolic syndrome. J Clin Endocrinol Metab 2003;88:1637-46
32. Ferretti G, Bacchetti T, Moroni C, Savino S, Liuzzi A, et al. Paraoxonase activity in high-density lipoproteins: a comparition between healthy and obese females. J Clin Endocrinol Metab 2005;90:1728-33
33. Molna r D, Decsi T, Koletzko B. Reduced antioxidant status in obese children with multimetabolic syndrome. Int J Obes Relat Metab Disord 2004;28:1197-202
34. Weghuber D, Roden M, Franz C, Chme lik M, Torabia S, et al. Vascular function in obese children with non-alcoholic fatty liver disease. Int J Pediatr Obes 2011;6:120-7
35. Goswami B, Tayal D, Gupta N, Mallika V. Paraoxonase: a multifaceted biomolecule. Clinica Chimica Acta 2009;410: 1-12
36. Ruperez AL, Lopez-Guarnido O, Olza J, Gil-Campos M, Leis R, et al. Paraoxonase 1 activities and genetic variation in childhood obesity. Br J Nutr 2013;110:1639-47